Richard Delarue

6.2k total citations
91 papers, 2.1k citations indexed

About

Richard Delarue is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Richard Delarue has authored 91 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 37 papers in Genetics and 34 papers in Oncology. Recurrent topics in Richard Delarue's work include Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (33 papers) and Viral-associated cancers and disorders (19 papers). Richard Delarue is often cited by papers focused on Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (33 papers) and Viral-associated cancers and disorders (19 papers). Richard Delarue collaborates with scholars based in France, Belgium and United States. Richard Delarue's co-authors include G Tardieu, Olivier Hermine, Corinne Haïoun, P.J.R. Laybourn, Hervé Tilly, Nicole Brousse, George Stewart, C. Millar, Christopher J. Wilkinson and Bertrand Coiffier and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Applied Physics Letters.

In The Last Decade

Richard Delarue

86 papers receiving 2.0k citations

Peers

Countries citing papers authored by Richard Delarue

Since Specialization

Citations

This map shows the geographic impact of Richard Delarue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Delarue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Delarue more than expected).

Fields of papers citing papers by Richard Delarue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Delarue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Delarue. The network helps show where Richard Delarue may publish in the future.

Co-authorship network of co-authors of Richard Delarue

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Delarue. A scholar is included among the top collaborators of Richard Delarue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Delarue. Richard Delarue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES 2023 ·HemaSphere ·Constantine S. Tam, Mazyar Shadman, Jeff P. Sharman, Gavin Cull, Tycel Phillips, Judith Trotman, Aileen Cohen, (unknown), (unknown), Richard Delarue, Heather Zhang, (unknown), (unknown), Ying Ou, Ian W. Flinn	1
2	Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial 2022 ·Blood Advances ·Vincent Camus, Aurélien Belot, Lucie Obéric, David Sibon, Hervé Ghesquières, Catherine Thiéblemont, Christophe Fruchart, Olivier Casasnovas, Jean‐Marie Michot, Thierry Jo Molina, André Bosly, (unknown), Corinne Haïoun, Emmanuelle Nicolas‐Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Hervé Tilly	8
3	A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 2019 ·Clinical Lymphoma Myeloma & Leukemia ·Carmelo Carlo‐Stella, Richard Delarue, Lydia Scarfò, Prajak J. Barde, (unknown), Silvia L. Locatelli, Lucia Morello, Massimo Magagnoli, Swaroop Vakkalanka, Srikant Viswanadha, Andrés J.M. Ferreri	20
4	Home Administration of Subcutaneous Rituximab Is Safe and Associated with Significant Cost Saving: A Single Center Experience 2017 ·Blood ·Alice Wolfromm, (unknown), (unknown), (unknown), Richard Delarue	5
5	Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study 2017 ·European Journal of Cancer ·Alexandre Morel, Josette Brière, Laurence Lamant, Michaël Loschi, Corinne Haïoun, Richard Delarue, Olivier Tournilhac, Emmanuel Bachy, Anne Sonet, Sandy Amorim, Camille Laurent, Philippe Gaulard, Hervé Tilly, David Sibon	15
6	BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial 2017 ·Annals of Oncology ·Tony Petrella, Christiane Copie‐Bergman, Josette Brière, Richard Delarue, Fabrice Jardin, Philippe Ruminy, Catherine Thiéblemont, Martin Figeac, Danielle Canioni, Pierre Feugier, Bettina Fabiani, Karen Leroy, Marie Parrens, Marc André, Corinne Haïoun, Gilles Salles, Philippe Gaulard, Hervé Tilly, (unknown), Thierry Jo Molina	14
7	Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study 2015 ·Haematologica ·Morgane Cheminant, Coralie Derrieux, Aurore Touzart, Stephanie L. Schmit, A Grenier, (unknown), Marie‐Hélène Delfau‐Larue, Ludovic Lhermitte, Catherine Thiéblemont, Vincent Ribrag, S. Chèze, Laurence Sanhès, (unknown), (unknown), Richard Delarue, Eva Hoster, (unknown), Vahid Asnafi, Olivier Hermine, Elizabeth Macintyre	43
8	Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA 2014 ·Clémentine Sarkozy, Nicolas Mounier, Alain Delmer, Achiel Van Hoof, (unknown), (unknown), Marie Maerevoet, (unknown), Richard Delarue, Michel Fabbro, Bertrand Coiffier	15
9	Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B) 2012 ·Annals of Oncology ·Nicolas Ketterer, (unknown), Catherine Thiéblemont, Christophe Fermé, J Brière, Olivier Casasnovas, Serge Bologna, B. Christian, Thierry Connerotte, Christian Récher, Dominique Bordessoule, Christophe Fruchart, Richard Delarue, Christophe Bonnet, F. Morschhauser, Bruno Anglaret, Carole Soussain, Bettina Fabiani, H. Tilly, Corinne Haïoun	21
10	Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d’Etude des Lymphomes de l’Adulte (GELA) 2012 ·European Journal of Cancer ·Vincent Ribrag, Hervé Tilly, Olivier Casasnovas, André Bosly, Réda Bouabdallah, Richard Delarue, François Boué, Dominique Bron, Pierre Feugier, Corinne Haïoun, (unknown), Bertrand Coiffier	14
11	First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor 2011 ·Advances in Therapy ·François Lefrère, (unknown), Caroline Elie, Jean‐Antoine Ribeil, Michael Bernimoulin, (unknown), Liliane Dal Cortivo, Richard Delarue, Olivier Hermine, Marina Cavazzana	50
12	Enteropathy-associated T-cell lymphoma: A review on clinical presentation, diagnosis, therapeutic strategies and perspectives 2010 ·Gastroentérologie Clinique et Biologique ·Marie‐Olivia Chandesris, Georgia Malamut, Virginie Verkarre, Bertrand Meresse, Elizabeth Macintyre, Richard Delarue, Marie‐Thérèse Rubio, Felipe Suárez, Bénédicte Deau, Nadine Cerf–Bensussan, Nicole Brousse, Christophe Cellier, Olivier Hermine	35
13	Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival—A Study From the Groupe d'Etude des Lymphomes de l'Adulte 2009 ·Journal of Clinical Oncology ·Emmanuel Bachy, Pauline Brice, Richard Delarue, Nicole Brousse, Corinne Haïoun, Steven Le Gouill, Alain Delmer, Dominique Bordessoule, Hervé Tilly, Bernadette Corront, Christian Allard, Charles Foussard, André Bosly, Bertrand Coiffier, Christian Gisselbrecht, Philippe Solal‐Céligny, Gilles Salles	50
14	90yttrium Ibritumomab Tiuxetan (zevalin) Combined With Beam (z-beam) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed Or Refractory Follicular Lymphoma. a Gela Phase Ii Prospective Study 2009 ·Digital Access to Libraries ·Christian Gisselbrecht, Didier Decaudin, Nicolas Mounier, Hervé Tilly, Vincent Ribrag, Catherine Sebban, Nöel Milpied, Franck Morschhauser, Bertrand Coiffier, Steven Le Gouill, P Lederlin, Richard Delarue, G. Laurent, André Bosly	1
15	Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma: A GELA Study 2008 ·Journal of Clinical Oncology ·Catherine Sebban, Pauline Brice, Richard Delarue, Corinne Haïoun, Bertrand Souleau, Nicolas Mounier, Nicole Brousse, Pierre Feugier, Hervé Tilly, Philippe Solal‐Céligny, Bertrand Coiffier	97
16	The Clinical Spectrum of IgM-Related Amyloidosis 2008 ·Medicine ·Benjamin Terrier, Arnaud Jaccard, Jean‐Luc Harousseau, Richard Delarue, Olivier Tournilhac, Mathilde Hunault, M. Hamidou, Jacques Dantal, Marc Bernard, B. Grosbois, Pierre Morel, Valérie Coiteux, O. Gisserot, Philippe Rodon, A. Hot, Caroline Elie, Véronique Leblond, Jean‐Paul Fermand, Fádi Fakhouri	54
17	Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis 2006 ·Leukemia & lymphoma ·Hossein Mossafa, Diane Damotte, (unknown), Richard Delarue, (unknown), (unknown), (unknown), Elie Khoury, (unknown), T. Samson, (unknown), Georges Flandrin, Xavier Troussard	47
18	La fuite urinaire d'érythropoïétine : une cause méconnue d'anémie au cours des syndromes néphrotiques 2006 ·La Revue de Médecine Interne ·Benjamin Terrier, Fádi Fakhouri, Philippe Sultanik, Richard Delarue, Aurélie Hummel	2
19	Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma 2004 ·The Hematology Journal ·Olivier Hermine, Hervé Dombret, Joël Poupon, (unknown), François Lefrère, (unknown), Gandhi Damaj, Richard Delarue, Jean Paul Fermand, Jean Claude Brouet, (unknown), B Varet, Hugues de Thé, Ali Bazarbachi	99
20	[Electroencephalographic study of retarded children of alcoholic parents; comparison with other groups of normal and retarded children]. 1952 ·PubMed ·(unknown), A Soulairac, (unknown), Richard Delarue	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact